🏥 治験ポータル
← 治験一覧に戻る

血漿由来エクソソームの皮膚創傷治癒への影響

基本情報

NCT ID
NCT02565264
ステータス
不明
試験のフェーズ
早期第1相
試験タイプ
介入
目標被験者数
5
治験依頼者名
Kumamoto University

概要

This study is an open prospective clinical trial. The objective is to evaluate the effect of autologous exosomes rich plasma on cutaneous wound healing. The participants are patients with intractable cutaneous ulcers (e.g. rheumatic disease, peripheral arterial disease, chronic venous insufficiency, decubitus or burns). The participants will be treated autologous exosomes rich plasma every day for 28 days. The cutaneous wound healing will be evaluated by the length, width and depth of the wound.

対象疾患

Ulcer

介入

plasma-derived exosomes(OTHER)

依頼者(Sponsor)

実施施設 (1)

くりはら形成外科・皮フ科・美容皮フ科

Kumamoto, Japan